Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chiara Giubbi has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Insights into Arcanobacterium haemolyticum: A Narrative Review of an Emerging Pathogen Revisited

    by Alessandra Consonni, Elena Briozzo, Chiara Giubbi, Silvia Tonolo, Francesco Luzzaro, Carola Mauri

    Arcanobacterium haemolyticum is a facultative anaerobic, Gram-positive bacillus that has garnered attention due to its role in human infections, particularly among adolescents and young adults. Traditionally associated with pharyngitis, this organism is increasingly recognized for its involvement in systemic infections, including bacteremia, central nervous system abscesses, and Lemierre’s syndrome. The pathogenicity of A. haemolyticum is attributed to its production of hemolysins and neuraminidase, facilitating tissue invasion and immune evasion. Clinically, infections often present with sore throat, fever, and a characteristic scarlatiniform rash, which can lead to their misdiagnosis as streptococcal pharyngitis. Severe manifestations, though rare, have been documented, particularly in immunocompromised individuals. Diagnosis is challenging due to the organism’s slow growth and potential misidentification as diphtheroids in cultures. Accurate identification necessitates specific culture conditions and biochemical testing. Treatment typically involves beta-lactam antibiotics; however, the emergence of resistance patterns necessitate susceptibility testing to guide therapy. This review aims to consolidate current knowledge on A. haemolyticum, emphasizing its clinical presentations, diagnostic challenges, and management strategies, thereby enhancing recognition and treatment of infections caused by this emerging pathogen.


  • Open Access

    The Emergence of Bacteroides pyogenes as a Human Pathogen of Animal Origin: A Narrative Review

    by Carola Mauri, Chiara Giubbi, Alessandra Consonni, Elena Briozzo, Elisa Meroni, Francesco Luzzaro, Silvia Tonolo

    Bacteroides pyogenes is a Gram-negative obligate anaerobe rod. It is naturally found in the oral microbiome of cats and dogs, which represents a primary source of disease for humans. The present review provides an update on the role of B. pyogenes as a pathogen responsible for infections in humans. Indeed, an increasing number of B. pyogenes infections have been reported in recent years, including skin and soft tissue infections as well as severe diseases like osteomyelitis, Lemierre’s syndrome, and bloodstream infection. Pre-analytical and analytical phases are crucial to guarantee the isolation of anaerobic bacteria, including B. pyogenes. Moreover, the introduction of MALDI-TOF mass spectrometry and 16S rRNA sequencing in clinical microbiology laboratories may be partially responsible for the increasing number of reports of B. pyogenes infections. However, the mechanisms underlying the pathogenicity of B. pyogenes remain poorly understood and require further investigations. Indeed, despite common antimicrobial susceptibilities, infections frequently persist and require multiple courses of antibiotics. In addition, based on literature data, this review indicates that treatment of skin and soft tissue infections often necessitates surgical procedures and hospitalization.


  • Open Access

    Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Pathogens in Cervical and Self-Collected Specimens

    by Chiara Giubbi, Marianna Martinelli, Michelle Rizza, Maria Letizia Di Meo, Ruth Chinyere Njoku, Federica Perdoni, Giulio Mannarà, Rosario Musumeci, Robert Fruscio, Fabio Landoni, et al.

    This study investigated the detection of high-risk Human Papillomavirus (hrHPV) and seven other pathogens associated with sexually transmitted infections (STIs) in matched clinician-collected cervical samples and self-taken vaginal and urine specimens collected from 342 asymptomatic women referred to colposcopy to evaluate (i) the concordance in the molecular detection of investigated pathogen in three different sample types; (ii) the analytical sensitivity and specificity of STIs detection on self-samples; and (iii) the distribution of STIs in hrHPV-positive and hrHPV-negative women. Pathogens detection was performed using Anyplex™II HR and Anyplex™II STI-7e, respectively. Good/substantial agreement was observed between cervical and self-taken samples in detecting hrHPV (κ = 0.870 and κ = 0.773 for vaginal and urine). The agreement between cervical and self-taken samples for detecting STIs was found to be significant (κ = 0.779 and κ = 0.738 for vaginal and urine), with almost perfect agreement between urine and vaginal specimens (κ = 0.899). The positivity rate for all investigated STIs was found to be higher in hrHPV-positive compared to hrHPV-negative women. In conclusion, self-sampling proved to be a valid alternative to cervical samples to detect hrHPV and STIs, but further studies are required to evaluate the role of STI coinfections in cervical lesions development and progression.


  • Open Access

    Wastewater Surveillance for SARS-CoV-2 in Northern Italy: An Evaluation of Three Different Gene Targets

    by Giulio Mannarà, Marianna Martinelli, Chiara Giubbi, Michelle Rizza, Eleonora Giordano, Federica Perdoni, Erika Bruno, Annalisa Morella, Arianna Azzellino, Andrea Turolla, et al.

    Wastewater-based epidemiology has emerged as a complementary tool for the monitoring of COVID-19 pandemic waves and for the circulation of viral variants. The selection, standardization, and dynamics of different SARS-CoV-2 RNA targets in wastewater requires further investigation. In the present study, 106 wastewater samples were collected over a 24-month period from the wastewater treatment plant of Sondrio, north Italy, and were analyzed for the presence of SARS-CoV-2 RNA through the quantification of ORF1b, N1, and N3 gene targets via one-step real-time qPCR. In general, the three RNA targets demonstrated different performances and dynamics over the studied time period, underlying the usefulness of multiple viral targets in the surveillance of SARS-CoV-2 in wastewater. During the first 12 months, the quantification of the selected SARS-CoV-2 viral targets also correlated with the reported clinical cases in the same geographical area; however, from the overall data analysis this did not appear to significantly anticipate the epidemic waves. In conclusion, this study further supports the use of wastewater surveillance as a real time indicator of the human circulation of SARS-CoV-2. Moreover, the use of multiple viral gene targets has been shown to improve the reliability of SARS-CoV-2 surveillance in wastewater over time.


  • Open Access

    Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Pathogens in Cervical and Self-Collected Specimens of Women Referred to Colposcopy

    by Chiara Giubbi, Marianna Martinelli, Michelle Rizza, Maria Letizia Di Meo, Ruth Chinjere Njoku, Federica Perdoni, Giulio Mannarà, Rosario Musumeci, Robert Fruscio, Fabio Landoni, et al.

    High-risk Human Papillomavirus (hrHPV) persistent infection is acknowledged as the primary cause of cervical cancer. Coinfection with other sexually transmitted infections (STIs) may be associated with a higher risk of cervical lesion progression. This study investigated the detection of hrHPV and 7 other STIs in matched clinician-collected cervical samples and self-taken vaginal and urine specimens of 345 asymptomatic women referred to colposcopy for abnormal cervical cytology. The association of sexually transmitted coinfections with cervical dysplasia was evaluated. Detection of hrHPV and 7 other sexually transmitted pathogens was carried out using Anyplex™II HR and Anyplex™II STI-7e, respectively. The positivity of hrHPV infections in cervical, vaginal and urine samples were respectively 67.0%, 71.3% and 68.1%, while STIs were detected in 47.9%, 57.9% and 56.4%. A good analytical agreement was observed between cervical and self-taken samples for hrHPV and STIs detection. STIs positivity rate was found to be higher in hrHPV-positive compared to hrHPV-negative women, but no association was found between STIs coinfections and the grade of cervical lesions. In conclusion, self-collected specimens proved to be a valid non-invasive alternative to cervical samples to detect hrHPV and STIs. Longitudinal studies are required to evaluate the role of STIs coinfections in lesions progression.

  • Open Access

    Clinical Performance of OncoPredict HPV Screening Assay on Self‐Collected Vaginal and Urine Specimens Within the VALHUDES Framework

    by Chiara Giubbi, Marianna Martinelli, Ardashel Latsuzbaia, Kate Cuschieri, Hana Elasifer, Anna Daniela Iacobone, Fabio Bottari, Andrea Fausto Piana, Roberto Pietri, Giancarlo Tisi, et al.

    The introduction of self‐sampling in cervical cancer screening has raised the importance of HPV test validation on self‐collected samples. This study aimed to evaluate the clinical accuracy of the OncoPredict HPV Screening (SCR) assay on self‐collected vaginal and first‐void urine (FVU) samples, relative to cervical specimens, using the VALHUDES Framework. FVU and vaginal self‐samples followed by a clinician‐collected cervical brushing were collected from 500 women referred to colposcopy and tested using OncoPredict HPV SCR assay. The assay demonstrated clinical sensitivity to detect cervical intraepithelial neoplasia grade 2 or worse (≥ CIN2) similar to cervical samples in FVU (ratio: 0.95, [95% CI: 0.88–1.02]) and vaginal self‐samples (ratio: 0.96 [95% CI: 0.90–1.02]). The clinical specificity for < CIN2 was lower in vaginal (ratio: 0.90 [95% CI: 0.84–0.96]) but not in FVU samples (ratio: 1.03 [95% CI: 0.96–1.12) when compared to cervical samples. However, the relative specificity improved following cut‐off optimization (ratio: 0.94, 95% CI: [0.88–1.01]). Moderate to excellent agreement in HPV detection between self‐collected and cervical samples was demonstrated (Kappa values: 0.53–1.00). To conclude, OncoPredict HPV SCR assay demonstrated similar accuracy on FVU and cervical samples. On vaginal compared to cervical samples sensitivity was similar with a lower specificity, which improved with cut‐off optimization.


  • Open Access

    Evaluation of C-C Motif Chemokine Receptor 5 (CCR5) as a Sample Adequacy Control in HPV Molecular Diagnostics

    by Ruth C. Njoku, Marianna Martinelli, Chiara Giubbi, Sofia De Marco, Barbara Torsello, Morena D’avenia, Manuela Sironi, Cristina Bianchi, Clementina E. Cocuzza

    Background: Reliable Human Papillomavirus (HPV) testing and genotyping are essential for quality assurance in HPV-based primary screening, disease management and for monitoring the impact of HPV vaccination. The clinical validation of HPV molecular diagnostic assays has significantly contributed to these objectives; however, little emphasis has been placed on assuring sample quality. This study aimed to evaluate the accuracy of sample cellularity assessment using the C-C Motif Chemokine Receptor 5 (CCR5) gene target as a marker of sample adequacy in molecular diagnostics. Methods: Jurkat cell line samples were counted using both a Thoma cell-counting chamber and Fluorescence-Activated Cell Sorting (FACS). Jurkat cell line samples at three different concentrations were subsequently evaluated using the OncoPredict HPV Quality Control (QC) real-time PCR assay, employing CCR5 for molecular cellularity quantification. Results: The cellularity values obtained were comparable across the three different methods for all dilutions of the cell line tested. Conclusions: The results obtained from this study show that CCR5 represents a promising molecular marker for the accurate quantification of sample cellularity, confirming its use as a reliable sample adequacy control, thus reducing the risk of “false-negative” results.


  • Open Access

    Evaluation of C-C Motif Chemokine Receptor 5 (CCR5) as a Sample Adequacy Control in HPV Molecular Diagnostics

    by Ruth Chinyere Njoku, Marianna Martinelli, Chiara Giubbi, Sofia De Marco, Barbara Torsello, Morena D'Avenia, Manuela Sironi, Cristina Bianchi, Clementina Elvezia Cocuzza

    Background: Reliable HPV testing and genotyping are essential for quality assurance in HPV-based primary screening, disease management and for monitoring the impact of HPV vaccination. The clinical validation of HPV molecular diagnostic assays has significantly contributed to these objectives, however little emphasis has been placed in assuring sample quality. This study aims to assess the accuracy of sample cellularity assessment using C-C Motif Chemokine Receptor 5 (CCR5) gene target as a marker of sample adequacy in molecular diagnostics. Methods: Jurkat cell line samples were counted both using Thoma cell-counting chamber and Fluorescent-Activated Cell Sorting (FACS). Jurkat cell line samples at three different concentrations were subsequently evaluated using the OncoPredict HPV Quality Control (QC) real-time PCR assay, employing CCR5 for molecular cellularity quantification. Results: Cellularity values obtained were comparable across the 3 different methods for all dilutions of the cell line tested. Conclusions: The results obtained from this study show that CCR5 represents a promising molecular marker for the accurate quantification of sample cellularity, confirming its use as a reliable sample adequacy control, thus reducing the risk of “false negative” results.


  • Open Access

    Analytical and clinical performance of OncoPredict HPV Screening (SCR) assay on self-collected vaginal and urine specimens within the VALHUDES Framework

    by Chiara Giubbi, Marianna Martinelli, Ardashel Latsuzbaia, Kate Cuschieri, Hana Elasifer, Anna Iacobone, Fabio Bottari, Andrea Piana, Roberto Pietri, Giancarlo Tisi, et al.

    The introduction of self-sampling in cervical cancer screening has raised the importance of HPV testvalidation on self-collected samples. This study aimed to evaluate the clinical performance of the OncoPredict HPV Screening (SCR) assay on self-collected vaginal and first-void urine (FVU) as part of the VALHUDES framework. Vaginal (FLOQSwabs) and FVU (Colli-Pee) samples were self-collected by 500 women referred to colposcopy, followed by a clinician-collected cervical sample prior to colposcopy, which were all tested using OncoPredict HPV SCR. OncoPredict HPV SCR demonstrated similar relative clinical sensitivity to detect cervical intraepithelial neoplasia grade 2 or worse (≥ CIN2) in urine (ratio: 0.95 [95%CI 0.88-1.02]) and vaginal self-samples (ratio: 0.96 [95%CI 0.90-1.02]) compared to cervical samples. The clinical specificity was lower in vaginal but not in urine samples compared to cervical which improved following cut-off optimization. A higher cellularity was found in vaginal as compared to cervical and FVU samples. Moderate to excellent agreement in HPV detection in self-collected samples and cervical scrapes was demonstrated (Kappa values: 0.53 to 1.00). OncoPredict HPV SCR assay demonstrated similar accuracy on self-collected vaginal and FVU samples compared to cervical samples, although cut-off adjustment improved clinical specificity when applied to vaginal samples.

  • Open Access

    Analysis of Human Papillomavirus 51 (HPV51) Genetic Variations Detected in Women with Cervical Dysplasia

    by Chiara Giubbi, Chiara Villa, Maria Letizia Di Meo, Illari Sechi, Ruth Chinyere Njoku, Narcisa Muresu, Federica Perdoni, Andrea Fausto Piana, Roberto Pietri, Robert Fruscio, et al.

    HPV51 belongs to group I high-risk HPV (hrHPV) genotypes with a high prevalence of infection in numerous epidemiological studies, although its occurrence varies across geographical regions. To better understand the presence of variants and genetic variation of HPV51, this study aimed to perform a phylogenetic analysis of the E6, E7 and L1 regions to detect the hrHPV variants circulating in women referred to colposcopy in two different Italian regions (Lombardy and Sardinia). Cervical samples were tested using Anyplex™ II HPV HR Detection. HPV51 positive samples were further analysed using previously described PCR protocols to obtain sequences of E6, E7 and L1. A positivity rate for HPV51 of 7.4% (26/351) and 13.6% (11/81) was found in Lombardy and Sardinia, respectively. The majority (34 out of 35) of the analyzed sequences clustered into the A lineage and only one sequence was grouped into B lineage. L1 capsid gene showed the presence of different mutations but none under positive selective pressure. Three nucleotide polymorphisms T6311G, A6312T and G6313A related to the two aminoacidic mutations V264G and G265S were found among all analysed sequences. This study contributes to implement data regarding the molecular epidemiology of HPV but additional analysis on a larger number of sequences is necessary to better understand the role of HPV variants in cervical lesions development.